Laryngopharyngeal reflux: A literature review

Surgeon

Volumn 4, Issue 4, 2006, Pages 221-225

  Khan, Anwar Moin ^a,d   Hashmi, S R ^b   Elahi, F ^a   Tariq, M ^c   Ingrams, D R ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b WEXHAM PARK HOSPITAL   (United Kingdom)

^c MAYO HOSPITAL   (Pakistan)

^d NONE   (United Kingdom)

Author keywords

Heartburn; Laryngopharyngeal reflux; Upper aerodigestive tract; Voice disorders

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ALCOHOL WITHDRAWAL; ANTIREFLUX OPERATION; BEHAVIOR MODIFICATION; CLINICAL FEATURE; CLINICAL PRACTICE; COUGHING; DIET RESTRICTION; DISEASE SEVERITY; DYSPHAGIA; FEEDING BEHAVIOR; FOREIGN BODY; HEARTBURN; HUMAN; LARYNGOPHARYNGEAL REFLUX; LIFESTYLE; LOW FAT DIET; MEDICAL LITERATURE; NOSE DISEASE; OTORHINOLARYNGOLOGY; PATHOPHYSIOLOGY; PH MEASUREMENT; REVIEW; SCORING SYSTEM; SMOKING CESSATION; SORE THROAT; SYMPTOM; THROAT DISEASE; UNITED KINGDOM; WEIGHT REDUCTION;

EID: 33746763512     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(06)80063-6     Document Type: Review

References (51)

1. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127(1):32-35.
2. Sung MW, Roh JL, Park BJ, Park SW, Kwon TKm Lee SJ et al. Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 2003;113(6):1059-63.
3. Koufman JA. The Otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24 hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101 (Suppl 52):1-78.
4. Bain WM, Harrington JW, Thomas LE, Schaefer SD. Head and neck manifestations of gastroesophageal reflux. Laryngoscope 1983;93:175-79.
5. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for oesophageal adenocarcinoma. N Eng J Med 1999;340:825-31.
6. Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985;94:516-19.
7. Postma GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol 2000;109(Suppl 184):10-14.
8. Hamdan AL, Sharara AI, Younces A, Fuleihan N. Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. Acta Otolaryngol 2001;121(7):868-72.
9. Lewin JS, Gillenwater AM, Garrett JD, Bishop-Leone JK, Nguyen DD, Callender DL et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer 2003;97(4):1010-14.
10. Vincent DA, Jr., Garrett JD, Radionoff SL, Reussner LA, Stasney CR. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 2000;14(2):247-54.
11. Richardson BE, Heywood BM, Sims HS, Stoner J, Leopold DA. Laryngopharyngeal reflux: trends in diagnostic interpretation criteria. Dysphagia 2004;19:248-55.
12. Merati AL, Lim HJ, Ulualp SO, Toohill RJ. Meta-analysis of upper probe measurements in normal subjects and patients laryngopharyngeal reflux. Ann Otol Rhinol Laryngol 2005;114:177-82.
13. Richter JE. Ambulatory esophageal pH monitoring: practical approach and clinical application. 2nd ed. New York: Igaku-Shoin., 1997.
14. Axford SE, Sharp N, Ross PE, Pearson JP, Dettmar PW, Panetti M et al. Cell biology of laryngeal epithelial defenses in health and disease: preliminary studies. Ann Otol Rhinol Laryngol 2001;110(12):1099-108.
15. Ossakow SJ, Elta G, Colturi T, Bogdasarian R, Nostrant TT. Esophageal reflux and dysmotality as the basis for persistant cervical symptoms. Ann Otol Rhinol Laryngol 1987;96:387-92.
16. Postma GN, Tomek MS, Belafsky PC, Koufman JA. Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease. Ann Otol Rhinol Laryngol 2001;110(12):1114-16.
17. Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123(4):385-8.
18. Reulbach TR, Belafsky PC, Blalock PD, Koufman JA, Postma GN. Occult laryngeal pathology in a community-based cohort. Otolaryngol Head Neck Surg 2001;124(4):448-50.
19. Copper MP, Smit CF, Stanojcic LD, Devries PP, Schouwenburg PF, Mathus-Vliegen LM. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope 2000;110(6):1007-11.
20. Freije JE, Beatty TW, Campbell BH, Schultz CJ, Toohill RJ. Carcinoma of larynx in patients with gastroesophageal reflux. Am J Otolaryngol. 1996;17:386-90.
21. Dagli S, Dagli U, Kurtaran H, Alkim C, Sahin B. Laryngopharyngeal reflux in laryngeal cancer. Turk J Gastroenterol 2004;15(2):77-81.
22. Wiener GJ, Cooper JB, Wu WC, Koufman JA, Richter JE, D.O. C. Is hoarseness an atypical manifestation of gastroesophageal reflux (GER)? An Ambulatory 24 hour pH study. Gastroenterology 1986;90:A1691.
23. Wiener GJ, Koufman JA, Wu W, Cooper WJ, Richter JE, Castell DO. Chronic hoarseness secondary to gastro-esophageal reflux disease: documentation with 24 hour ambulatory pH monitoring. Am J Gastroenterol 1989;84:1503-8.
24. Olson NR. Effects of stomach acid on larynx. Proc Am Laryngol Assoc 1983;104:108-12.
25. Wiener GJ, Koufman JA, Wu WC, Cooper JB, Richter JE, Castell DO. The pharyngoesophageal dual ambulatory pH probe for evaluation of atypical manifestation of gastroesophageal reflux (GER). Gastroenterology 1987;92: A1694.
26. Koufman JA, Wiener GJ, Wu WC, Richter JE, Castell DO. Reflux larynx and its sequelae: the diagnostic role of ambulatory 24-hour pH monitoring. J Voice 1988;2:78-89.
27. Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 1968;78:1941-47.
28. Ulualp SO, Toohill RJ. Laryngopharyngeal reflux: state of the art diagnosis and treatment. Otolaryngol Clin North Am 2000;33(4):785-802.
29. Belafsky PC, Postma GN, Koufman JA. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001;111(6):979-81.
30. Walner DL, Stem Y, Gerber ME, Rudolph C, Baldwin CY, Cotton RT. Gastroesophageal reflux in patients with subglottic stenosis. Arch Otolaryngol Head Neck Surg 1998;124:551-55.
31. Johnson PE, Koufman JA, Nowak LJ, Belafsky PC, Postma GN. Ambulatory 24-hour double-probe pH monitoring: the importance of manometry. Laryngoscope 2001;111:1970-75.
32. Vaezi ME, Shroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal monitoring. Am J Gasroenterol 1997;92:825-29.
33. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111(8):1313-17.
34. Belafsky PC. Abnormal endoscopic pharyngeal and laryngeal findings attributable to reflux. Am J Med 2003;115 Suppl 3A: 90S-96S.
35. Hanson DG, Jiang J, Chi W. Quantitative color analysis of laryngeal erythema in chronic posterior laryngitis. J Voice 1998;12:78-83.
36. Milko TL. Peptic (Contact ulcer) granuloma of the larynx. J Clin Pathol 1989;42:800-804.
37. Svensson G, Schelen L, Fex S. Pathogenesis of idiopathic contact granuloma of the larynx: results of a prospective clinical study. Acta Otolaryngol 1988;449:123-25.
38. Ylitalo R, Ramel S. Extraesophageal reflux in patients with contact granuloma: a prospective controlled study. Ann Otol Rhinol Laryngol 2002;111:441-46.
39. Hickson C, Simpson CB, Falcon R. Laryngeal pseudosulcus as a predictor of laryngopharyngeal reflux. Laryngoscope 2001;111(10):1742-45.
40. Heman-Ackah YD, Kelleher K, Sataloff RT. Inferior glottic ridges that prevent vocal fold closure. Ear Nose Throat J 2002;81:207-9.
41. Belafsky PC, Postma GN, Koufman JA. The association between laryngeal pseudosulcus and laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2002;126(6):649-52.
42. Mamede RC, De Mello-Filho FV, Vigario LC, Dantas RO. Effect of gastroesophageal reflux on hypertrophy of the base of the tongue. Otolaryngol Head Neck Surg 2000;122:607-10.
43. Helen JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis, Gastroenterology 1987;93:1393-97.
44. Kamel PL, Hanson D, Kahrilas PJ, Omeprazole for the treatment of posterior laryngitis. Am J Med 1994;96:321-26.
45. Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111(12):2147-51.
46. Galli J, Scarano S, Agostino S, Quaranta N, Cammarota G, Ottaviani F. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience. Acta Otorhinolaryngol Ital 2003;23(1):38-42.
47. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16(2):274-77.
48. Maceri DR, Zim S. Laryngospasm: an atypical manifestation of severe gastroeophageal reflux disease. Larygoscope 2001;111:1976-79.
49. Amin MR, Postma GN, Johnson P, Digges N, Koufman JA. Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2001;125(4):374-78.
50. Westcott CJ, Hopkins MB, Bach K, Postma GN, Belafsky PC, Koufman JA. Fundoplication for laryngopharyngeal reflux disease. J Am Coll Surg 2004;199(1):23-30.
51. Toohill RJ. Fundoplication for laryngopharyngeal reflux disease. J Am Coll Surg 2004;199(5):837; author reply 838.